Insider Trading Activity Editas Medicine, Inc. (NASDAQ:EDIT) – Insider Sold 16,666 shares of Stock

ME Staff
-
0

Insider Trading Activity For Editas Medicine, Inc. (NASDAQ:EDIT)

Katrine Bosley , Insider of Editas Medicine, Inc. (NASDAQ:EDIT) reportedly Sold 16,666 shares of the company’s stock at an average price of 20.02 for a total transaction amount of $333,653.32 SEC Form

Insider Trading History For Editas Medicine, Inc. (NASDAQ:EDIT)

  • On 2/8/2016 James E Flynn, Insider, bought 100,000 with an average share price of $16.00 per share and the total transaction amounting to $1,600,000.00.View SEC Filing
  • On 8/23/2016 Alexandra Glucksmann, COO, sold 1,000 with an average share price of $20.00 per share and the total transaction amounting to $20,000.00.View SEC Filing
  • On 9/6/2016 Kevin P. Starr, Major Shareholder, sold 5,890 with an average share price of $15.90 per share and the total transaction amounting to $93,651.00.View SEC Filing
  • On 9/8/2016 Polaris Venture Management Co., Major Shareholder, sold 500,000 with an average share price of $16.80 per share and the total transaction amounting to $8,400,000.00.View SEC Filing
  • On 11/15/2016 Kevin Bitterman, Director, sold 88,900 with an average share price of $16.96 per share and the total transaction amounting to $1,507,744.00.View SEC Filing
  • On 11/22/2016 Polaris Venture Management Co., Major Shareholder, sold 12,819 with an average share price of $15.77 per share and the total transaction amounting to $202,155.63.View SEC Filing
  • On 11/23/2016 Kevin Bitterman, Director, sold 21,480 with an average share price of $15.71 per share and the total transaction amounting to $337,450.80.View SEC Filing

    • Analyst Ratings For Editas Medicine, Inc. (NASDAQ:EDIT)
    These are 4 Hold Ratings, 3 Buy Ratings .
    The current consensus rating for Editas Medicine, Inc. (NASDAQ:EDIT) is Hold (Score: 2.43) with a consensus target price of $26.33 , a potential (13.70% upside)

    Analyst Ratings History For Editas Medicine, Inc. (NASDAQ:EDIT)

    • On 2/29/2016 JMP Securities Initiated Coverage of rating Outperform with a price target of $40.00
    • On 2/29/2016 Morgan Stanley Initiated Coverage of rating Equal to Equal Weight with a price target of $28.00
    • On 2/15/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $35.00
    • On 3/15/2017 Cowen and Company Reiterated Rating Buy
    • On 3/27/2017 Chardan Capital Initiated Coverage of rating Buy to Buy
    • On 7/13/2017 SunTrust Banks, Inc. Initiated Coverage of rating Hold to Hold with a price target of $17.00
    • On 7/18/2017 Oppenheimer Holdings, Inc. of rating Market Perform

    Recent Trading Activity for Editas Medicine, Inc. (NASDAQ:EDIT)
    Shares of Editas Medicine, Inc. closed the previous trading session at 23.16 up +1.21 5.51% with 1,722,799 shares trading hands.